Bone marrow aplasia after pipobroman: an immune-mediated mechanism?

Br J Haematol. 2001 Dec;115(3):713-4. doi: 10.1046/j.1365-2141.2001.03138-4.x.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia, Aplastic / chemically induced*
  • Anemia, Aplastic / drug therapy
  • Antineoplastic Agents, Alkylating / adverse effects*
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Chronic Disease
  • Cyclosporine / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Pipobroman / adverse effects*
  • Pipobroman / therapeutic use
  • Thrombocythemia, Essential / drug therapy
  • Thrombocythemia, Essential / immunology

Substances

  • Antineoplastic Agents, Alkylating
  • Immunosuppressive Agents
  • Pipobroman
  • Cyclosporine